Calculations based on bronchial morphology show that the concentrations of DCG used in these experiments may be attained therapeutically in the bronchial mucosa of man.
Disruption of mast cells was measured by incubating the peritoneal washings of a rat with the substances under test. The incubate was filtered and the histamine in the undisrupted mast cells on the filter was assayed using guinea-pig ileum. Measurements were also made on disruption of rat peritoneal mast cells in vivo.
Disodium cromoglycate (DCG) reduces the in vitro disruption of peritoneal mast cells produced by Compound 48/80, human plasma, dextran, and trypsin inhibitors. Compound 48/80 produced its greatest mast cell disruption at a calcium concentration of 0-2-2 mM CaCl2. DCG was effective in reducing the mast cell disruption at all calcium concentrations. Mast cell disruption by surface active agents was also reduced by DCG.
In vivo experiments showed that DCG reduced the disruptive effect of Compound 48/80 on rat mesenteric mast cells.
Calculations based on bronchial morphology show that the concentrations of DCG used in these experiments may be attained therapeutically in the bronchial mucosa of man.
Disodium cromoglycate (DCG) has been found to be effective in the treatment of asthma and it has been suggested that DCG acts at some point between the union of reagin antibody with antigen and the subsequent disruption of the mast cell (Cox, 1967; Goose and Blair, 1969) . This suggestion was based on the ability of DCG to inhibit the passive cutaneous anaphylactic reaction in rats, to reduce antigen-induced bronchoconstriction in marmosets, and to prevent release of spasmogens when antigen acts on sensitized lung tissue in vitro. On the other hand, DCG failed to affect skin lesions induced by Compound 48/80 and it therefore appeared to have no direct protective effect on the mast cell. This paper reports observations on the influence of DCG upon the action of various substances which cause disruption of rat peritoneal mast cells either in vitro or in vivo.
METHODS
MAST CELL DISRUPTION in vitro The method used to measure mast cell disruption follows closely that described by Lagunoff and Benditt (1960) . The principle of the method is that rat peritoneal mast cells, after incubation with a possible disrupting agent, are filtered through a membrane which holds back the intact mast cells (and possibly granules) but allows non-granular substances liberated from the mast cells to pass through. The histamine (and other active substances) is liberated from the mast cells retained on the filter by freezing first and thawing and it is then assayed on guinea-pig ileum.
The suspension of rat peritoneal mast cells was prepared as follows. A rat was anaesthetized with ether and bled by cutting across the heart and thorax with scissors. Twenty millilitres of low-calcium tyrode solution (Dalgleish, Toh, and Work, 1953) , to which 10 ,tg/ml of heparin was added, was introduced into the peritoneal cavity through a small incision and the abdominal wall was massaged for about one minute.
The peritoneal cavity was then opened widely by a midline incision and the fluid was removed using a plastic pipette. This suspension, in which mast cells constituted about 40/ of the total cells, was used without further purification or standardization of the mast cell content. The solutions, whose mast cell disrupting effect was to be tested, were pipetted, usually in 0-6-ml volumes, into 90 x 12 mm plastic tubes, and 0 7 ml of mast cell suspension was added from a syringe delivering a constant volume. The contents of one tube, in which the standard volume of mast cell suspension had been added to tyrode solution, were mixed and filtered immediately. This tube is designated 'initial' in the graphs shown below and represents the total histamine content of the mast cells. The other tubes were capped and incubated at 370 C for one hour before filtration. The suspensions were filtered through 25 mm diameter Millipore filters, 0-8 , pore diameter (Type AAWPO2500) supported in 38 'Swinnex' filter holders. The filters were washed through with two 2-ml quantities of saline and the filter discs were removed from the holders, folded, and placed in 2 ml of saline in a bijou bottle which was then frozen. The bottles were thawed just before assay of the histamine content on guinea-pig ileum in Kreb's solution at 370 C (Pharmacology Department Staff, University of Edinburgh. 1970) . The results are expressed as ng histamine/ml of the saline solution, although it is realized that serotonin and other substances liberated from the mast cells may be increasing the contraction of the guinea-pig ileum. In Figs 1 and 4 the histamine released from the undisrupted mast cells is expressed as a percentage of the histamine released from an equal volume of cell suspension before treatment with a disrupting agent.
An advantage of the filter disc method is that, for the most part, the substances used to induce or prevent mast cell disruption are removed before assay of histamine on the guinea-pig ileum. As an additional precaution the effect of the substances used was tested by adding them to the organ bath in the concentrations used for mast cell disruption. MAST CELL DISRUPTION in vivo White rats of about 300 g were anaesthetized with ether; 2-5 ml of tyrode solution (for the tyrode controls) or 2-5 ml of tyrode solution containing 1 mg of DCG were injected intraperitoneally. One minute later, while the rat was still anaesthetized, 2 5 ml of tyrode solution or 2 5 ml of tyrode containing 1 gg/ml of Compound 48/80 was injected intraperitoneally. The animals were allowed to recover from the anaesthesia and 5 minutes later were re-anaesthetized with ether and killed by cutting across the chest. The abdomen was opened and, by picking up the gut with forceps so that the mesentery was not handled, 'windows' of mesentery were stretched across 'embroidery-rings' of 12 mm diameter made from the tops of disposable plastic tubes. Three 'windows' were prepared from each rat. The mesenteries were fixed in 10% formol saline, stained with 0-1% acidic aqueous toluidine blue for one minute, rinsed with water, and examined under the microscope. One hundred mast cells were counted in each ring and the number of disrupted cells was recorded. In most of the cells recorded as disrupted the damage was marked with most of the granules widely dispersed. Cells with only a few granules outside the cell boundary, but which otherwise appeared intact, were recorded as not disrupted. The substances used to produce mast cell disruption were (1) Compound 48/80 (Wellcome Research Laboratories). This is a condensation product of pmethoxyphenethylmethylamine with formalin and is an effective mast cell disrupting agent in many species; (2) dextran, as Rheomacrodex (Pharmacia) of molecular weight 40,000 in normal saline; (3) aprotinin (Trasylol, FBA Pharmaceuticals Ltd.) in ampoules of 5,000 units per mil.; (4) ovomucoid from egg white (Sigma Chemicals Co. Type 11-0); (5) plasmin, grade B (Kabi Pharmaceuticals Ltd.); (6) urokinase (Leo Laboratories Ltd.) as the partially purified reference standard containing 2,400 Ploug units per ampoule.
RESULTS
The influence of DCG was studied on the mast cell disrupting effect of the following substances: Hydrocortisone has the property of stabilizing cell membranes; 1 mg of hydrocortisone (as the sodium succinate) added to the reaction tubes had an effect which was often comparable to that of 1 mg of DCG (Fig. 3) . (f) THROMBOLYTIC ENZYMES The thrombolytic enzymes tested were plasmin and urokinase, the latter in the form of the incompletely purified reference standard. Urokinase produced mast cell disruption when 200, 400, and 1,000 Ploug units were added to the reaction tubes. DCG reduced the mast cell disruption by over 50% in each case but the results were too few for statistical analysis. The results with plasmin were inconclusive. (Goth, 1959) . DCG for clinical use in the Spinhaler (Fisons Pharmaceuticals Ltd.) is combined with an equal weight of lactose. In view of the possible effect of lactose on mast cell disruption a comparison was made of the effect of lactose, DCG, and the DCG/lactose combination. Figure 5 shows that lactose by itself has no effect on mast cell disruption by Compound 48/80 and in combination with DCG there was no difference from the action ot DCG alone. (Cox, 1967; Goose and Blair, 1969) indicated that DCG had a specific action in blocking the effect of antigenantibody complex on the mast cell, later experiments by Orr and Cox (1969) have shown that DCG inhibits disruption of rat mast cells by phospholipase A. Orr suggested that there is a common pathway in mast cell disruption by phospholipase A and the antigen-antibody complex, but Keller (1966) has put forward reasons for believing that phospholipase is not involved in mast cell disruption by immune reactions.
I have investigated the effect of DCG on mast cell disruption in vitro by both phospholipase A and a-chymotrypsin which Keller (1966, p. 105) has suggested may be involved in mast cell disruption by antigen/antibody reactions. Although earlier workers (H6gberg and Uvnas, 1958) had demonstrated mast cell disruption by phospholipase-A from bee venom, Keller (1964) showed that purer phospholipase-A had no action unless a heat-labile serum factor was present. This finding has been confirmed in this laboratory in so far as large amounts of phospholipase-A (20-40 jtg) (Boehringer, Mannheim) in the test system produce only an additional 15% mast cell disruption as compared with a tyrode control. This additional mast cell disruption, however, is reduced by DCG. The presence of human serum in the test system usually produces 80-100% mast cell disruption with 2 rig of phospholipase-A. This disruption is usually reduced by DCG but the action of DCG is variable and in some instances increased mast cell disruption is produced.
In relatively high concentrations (50-100 xAg/ml) (Y-chymotrypsin caused mast cell disruption in tyrode solution and the effect was inhibited by DCG but the addition of either fresh or heatinactivated (60°C) human serum completely prevented mast cell disruption by a-chymotrypsin, a finding contrary to that of Keller (1966, p. 34) .
The mast cell counts on rat mesentery show that DCG has a protective effect against the disruptive action of Compound 48/80 in vivo, when the DCG is brought into direct contact with the mast cells in fairly high concentration. The concentration of DCG used in the tests reported here are much greater than those reported in the blood of man. Maximum blood levels after inhalation of DCG are reached in about 10 minutes and after inhalation of three 20-mg capsules the blood contains 0.25 uAg/ml (Fisons Pharmaceuticals Limited, 1968) . Plasma of blood taken from a subject 10 minutes after inhalation of five 20-mg capsules of DCG did not cause less mast cell disruption than control plasma taken before the inhalation.
Bronchial tissue levels of DCG after inhalation of the drug may be much higher than the blood levels. The surface area of the bronchial tree down to the level of airways with a diameter of about 1 mm is approximately 1,000 cm2 when calculated from the measurements of either Weibel (1963) or Horsfield and Cumming (1968 (Fanciullacci and Franchi, 1964) and 35-60 pg/kg produced an apparent increase in the proportion of degranulated mast cells in the bronchial mucosa (Salvato, 1962 
